Journal
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 139, Issue 10, Pages 3647-3650Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jacs.7b01124
Keywords
-
Categories
Funding
- NIH [GM105766]
- NSF
- Eli Lilly
- Novartis
- Bristol-Myers Squibb
- Amgen
- Boehringer-Ingelheim
- Sloan Foundation
- Baxter Foundation
Ask authors/readers for more resources
We report a concise chemical synthesis of kalihinol C via a possible biosynthetic intermediate, protokalihinol, which was targeted as a scaffold en route to antiplasmodial analogs. High stereocontrol of the kalihinol framework relies on a heterodendralene cascade to establish the target stereotetrad. Common problems of regio- and chemoselectivity encountered in the kalihinol class are explained and solved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available